This observational study investigated germline (inherited) mutations in patients with pancreatic adenocarcinoma, a type of pancreatic cancer. Patients diagnosed with pancreatic adenocarcinoma at any stage were included. The study had no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Patients diagnosed with adenocarcinoma of the pancreas * All disease stages Exclusion criteria * Patients with pancreatic cancer, other than adenocarcinoma * Non-eligible blood samples